INTERVIEW: LabStyle targets US Dario approval by year-end
This article was originally published in Clinica
“We’ve done a lot of research with people with diabetes and two main things come up regularly:firstly, they don’t want to feel like a sick person. Secondly, they say the current health support they’re getting doesn’t correlate with their data,” Dror Bacher, vice-president of R&D at LabStyle Innovations told Clinica.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.